Article
Six-month clinical results positive for dual-optic IOL
San Diego-First trial results with the Synchrony dual-optic accommodative IOL (Visiogen Inc.) indicate that this first-generation lens is safe and performs well. However, lens power calculations should improve via more IOL implantation and calculation adjustment, according to Gerd Auffarth, MD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
